Binnacle Investments Inc Evolus, Inc. Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Binnacle Investments Inc holds 475 shares of EOLS stock, worth $5,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
475Holding current value
$5,704% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
178Shares Held
50.4MCall Options Held
42.2KPut Options Held
2.5K-
Perceptive Advisors LLC New York, NY5.15MShares$61.8 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$60 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$48.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$38.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$37.6 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $674M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...